Skip to Main Content
Book cover for Oxford Handbook of Palliative Care (2 edn) Oxford Handbook of Palliative Care (2 edn)
Max Watson et al.

A newer edition of this book is available.

Close

Contents

Book cover for Oxford Handbook of Palliative Care (2 edn) Oxford Handbook of Palliative Care (2 edn)
Max Watson et al.
Disclaimer
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always … More Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

These are guides only—different labs use different ranges. Pregnant women and children also have different normal ranges—consult the lab.

MeasurementReference interval

White cell count (WCC)

4.0–11.0×109/l

Red cell count (RCC)

Men: 4.5–6.5×1012/l

 

Women: 3.9–5.6×1012/l

Haemoglobin

Men: 13.5–18g/dl

 

Women: 11.5–16.0g/dl

Packed cell volume (PCV) or haematocrit

Men: 38.5–50.1%

 

Women: 36.0–44.5%

Mean cell volume (MCV)

76–97fl

Mean cell haemoglobin (MCHC)

32.7–34.6 g/dl

Neutrophils

2.0–7.5×109/l 40–75% WCC

Lymphocytes

1.3–3.5×109/l 20–45% WCC

Eosinophils

0.04–0.44×109/l 1–6% WCC

Basophils

0.0–0.1×109/l 0–1% WCC

Monocytes

0.2–0.8×109/l 2–10% WCC

Platelet count

150–400×109/l

Reticulocyte count

25–100×109/l 0.8–2% RCC*

Erythrocyte sedimentation rate (ESR)

Depends on age

International normalized ratio (INR)

0.8–1.2

 

Ranges for warfarin therapy depend on indication

Prothrombin time (PTT)

12–17 sec.

Factors I, II, VII, X

Activated partial thromboplastin time

28–40 sec.

Factor VIII, IX, XI, XII

Red cell folate

180–300 ng/ml

MeasurementReference interval

White cell count (WCC)

4.0–11.0×109/l

Red cell count (RCC)

Men: 4.5–6.5×1012/l

 

Women: 3.9–5.6×1012/l

Haemoglobin

Men: 13.5–18g/dl

 

Women: 11.5–16.0g/dl

Packed cell volume (PCV) or haematocrit

Men: 38.5–50.1%

 

Women: 36.0–44.5%

Mean cell volume (MCV)

76–97fl

Mean cell haemoglobin (MCHC)

32.7–34.6 g/dl

Neutrophils

2.0–7.5×109/l 40–75% WCC

Lymphocytes

1.3–3.5×109/l 20–45% WCC

Eosinophils

0.04–0.44×109/l 1–6% WCC

Basophils

0.0–0.1×109/l 0–1% WCC

Monocytes

0.2–0.8×109/l 2–10% WCC

Platelet count

150–400×109/l

Reticulocyte count

25–100×109/l 0.8–2% RCC*

Erythrocyte sedimentation rate (ESR)

Depends on age

International normalized ratio (INR)

0.8–1.2

 

Ranges for warfarin therapy depend on indication

Prothrombin time (PTT)

12–17 sec.

Factors I, II, VII, X

Activated partial thromboplastin time

28–40 sec.

Factor VIII, IX, XI, XII

Red cell folate

180–300 ng/ml

*

Only use percentages as reference interval if red cell count is normal. Otherwise use absolute value.

Substance P Reference interval

Adrenocorticotrophic hormone

P

<80ng/l

Alanine aminotransferase (ALT)

P

5–35iu/l

Albumin

P

35–50g/l

Alkaline transaminase (AST)

P

30–150u/l

α-amylase

P

0–180u/dl

Aspartate transaminase (AST)

P

5–35iu/l

Bicarbonate

P

24–30mmol/l

Bilirubin

P

3–17μmol/l

Calcium (total)

P

2.12–2.26mmol/l

Creatine kinase (CK)

P

Men: 25–195iu/l

 

Women: 25–172iu/l

Creatinine (graphic see Chapter 8d)

P

70–≤150μmol/l

Ferritin

P

12–200μg/l

Folate

P

2.1μg/l

Follicle stimulating hormone (FSH)

P/S

2–8u/l>25u/l post menopause

Gamma-glutamyl transpeptidase (GGT, γGT)

P

Men: 11–51iu/l

 

Women: 7–33iu/l

Glucose (fasting)

P

3.5–5.5mmol/l

Iron

S

Men: 14–31μmol/l

 

Women: 11–30μmol/l

Luteinizing hormone (LH)

P

3–16u/l

Osmolality

P

278–305mosmol/kg

Phosphate (inorganic)

P

0.8–1.45mmol/l

Potassium

P

3.5–5.0mmol/l

Prolactin

P

Men: <450u/l

 

Women: <600u/l

Prostate specific antigen (PSA)(graphic see p.186)

P

0–4ngrams/ml

Protein (total)

P

60–80g/l

Sodium

P

135–145mmol/l

Thyroxine (T4)

P

70–140nmol/l

Total iron binding capacity

S

54–75μmol/l

Triglyceride

P

0.55–1.90mmol/l

Urate

P

Men: 210–480μmol/l

 

Women: 150–390μmol/l

Urea

P

2.5–6.7mmol/l

Vitamin B12

S

0.13–0.68nmol/l (>150ng/l)

Substance P Reference interval

Adrenocorticotrophic hormone

P

<80ng/l

Alanine aminotransferase (ALT)

P

5–35iu/l

Albumin

P

35–50g/l

Alkaline transaminase (AST)

P

30–150u/l

α-amylase

P

0–180u/dl

Aspartate transaminase (AST)

P

5–35iu/l

Bicarbonate

P

24–30mmol/l

Bilirubin

P

3–17μmol/l

Calcium (total)

P

2.12–2.26mmol/l

Creatine kinase (CK)

P

Men: 25–195iu/l

 

Women: 25–172iu/l

Creatinine (graphic see Chapter 8d)

P

70–≤150μmol/l

Ferritin

P

12–200μg/l

Folate

P

2.1μg/l

Follicle stimulating hormone (FSH)

P/S

2–8u/l>25u/l post menopause

Gamma-glutamyl transpeptidase (GGT, γGT)

P

Men: 11–51iu/l

 

Women: 7–33iu/l

Glucose (fasting)

P

3.5–5.5mmol/l

Iron

S

Men: 14–31μmol/l

 

Women: 11–30μmol/l

Luteinizing hormone (LH)

P

3–16u/l

Osmolality

P

278–305mosmol/kg

Phosphate (inorganic)

P

0.8–1.45mmol/l

Potassium

P

3.5–5.0mmol/l

Prolactin

P

Men: <450u/l

 

Women: <600u/l

Prostate specific antigen (PSA)(graphic see p.186)

P

0–4ngrams/ml

Protein (total)

P

60–80g/l

Sodium

P

135–145mmol/l

Thyroxine (T4)

P

70–140nmol/l

Total iron binding capacity

S

54–75μmol/l

Triglyceride

P

0.55–1.90mmol/l

Urate

P

Men: 210–480μmol/l

 

Women: 150–390μmol/l

Urea

P

2.5–6.7mmol/l

Vitamin B12

S

0.13–0.68nmol/l (>150ng/l)

P – plasma (e.g. heparin bottle); S – serum (clotted—no anticoagulant)

Lab reference values. Reproduced from Longmore M et al. (2007) The Oxford Handbook of Clinical Medicine, 7th edn. Oxford University Press. With permission
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close